PRQR Stock Analysis: Buy, Sell, or Hold?

PRQR - ProQR Therapeutics N.V. Ordinary Shares

Pharmaceutical Preparations
$1.79
0.08 (4.68%) β–²
5d: +1.7%
30d: +4.07%
90d: +9.15%
BUY
HIGH Confidence
Analysis Updated: Aug 4, 2026 12:00 AM ET
Earnings: Aug 06, 2026 1d

Get Alerted When PRQR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
βœ… BUY SIGNAL: PRQR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: PRQR is currently trading at $1.79, which is considered fair relative to its 30-day fair value range of $1.66 to $1.83.

Technical Outlook: Technically, PRQR is showing sideways momentum. Immediate support is located at $1.66, while resistance sits at $2.00. The stock is showing strong short-term momentum, up 4.7% recently.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.25 (+382.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $1.66 - $1.83
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 80.0%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.7%)
  • BULLISH: Trading 382.5% below Wall St target ($8.25)

Trading Range Analysis

30-Day Trading Range $1.66 - $1.83
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $1.66
Resistance Level $2.00
Current Trend Sideways
Technical data as of Aug 3, 2026

Fundamental Context

Forward P/E (Next Year Est.) -2.52
Wall Street Target $8.25 (+382.5%)
Revenue Growth (YoY) -57.1%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 04, 2026 1:59 PM ET
Data refreshes hourly during market hours. Next update: 2:59 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for PRQR.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$26 47 HOLD
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$834 51 HOLD
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$267 58 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 46 HOLD
ACAD
ACADIA Pharmaceuticals I…
BUY
20 analysts
$33 55 HOLD

More Analysis for PRQR

PRQR Technical Chart PRQR Price Prediction PRQR Earnings Date PRQR Investment Advisor PRQR Fair Price Analyzer PRQR Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals